• user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: INSERT into captcha_sessions (uid, sid, ip_address, timestamp, form_id, solution, status, attempts) VALUES (0, 'v4h2nre7u5d8qmhgk9f9ltdjv7', '38.107.191.118', 1268350225, 'user_login_block', 'undefined', 0, 0) in /persistent/html/sites/all/modules/captcha/captcha.inc on line 92.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: SELECT status FROM captcha_sessions WHERE csid = 0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 112.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: SELECT status FROM captcha_sessions WHERE csid = 0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 112.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: UPDATE captcha_sessions SET timestamp=1268350225, solution='1' WHERE csid=0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 104.

Browse all clinical trials

Sponsor Updatedsort icon
Phase I Radiolabeled Monoclonal Antibody Therapy Combined With Total-Body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or National Cancer Institute (NCI) 2009-05-20
Phase III Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors National Cancer Institute (NCI) 2009-05-20
Phase I A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer Bristol-Myers Squibb 2009-05-20
Phase III Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer National Cancer Institute (NCI) 2009-05-20
Phase I Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer EMD Serono 2009-05-20
Phase III A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies Bristol-Myers Squibb 2009-05-20
Phase II Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis Bristol-Myers Squibb 2009-05-20
Phase II Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy National Cancer Institute (NCI) 2009-05-20
Phase II Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-Menopausal Women AstraZeneca 2009-05-20
Phase II Phase II Study of Dasatinib (BMS-354825) for Androgen-Deprived Progressive Prostate Cancer Bristol-Myers Squibb 2009-05-20
Phase III Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness Bristol-Myers Squibb 2009-05-20
Phase IV A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers Organogenesis 2009-05-20
Phase III Comparison of Fulvestrant (FASLODEXâ„¢) 250 mg and 500mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. AstraZeneca 2009-05-20
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome Sociedad Española de Neumología y Cirugía Torácica 2009-05-20
Phase II A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase II Phase II Trial of Weekly or Every 3-Week Ixabepilone for Patients With Metastatic Breast Cancer (MBC) Bristol-Myers Squibb 2009-05-20
Phase I A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia Bristol-Myers Squibb 2009-05-20
Phase III Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Bristol-Myers Squibb 2009-05-20
A Belatacept Compassionate Use Study for Patients With a Kidney Transplant Bristol-Myers Squibb 2009-05-20
Phase II A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer Bristol-Myers Squibb 2009-05-20
Phase I Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase I A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) Bristol-Myers Squibb 2009-05-20
Phase III Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer National Cancer Institute (NCI) 2009-05-20
Phase I Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors Bristol-Myers Squibb 2009-05-20
Phase I A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors Bristol-Myers Squibb 2009-05-20